PDB9 Analisis De Costo–Efectividad Del Uso De Detemir En Diabetes Tipo 2 Frente Al Riesgo De Presentar Eventos Cardiovasculares Y Muerte
Nov 1, 2011, 00:00 AM
10.1016/j.jval.2011.08.1591
https://www.valueinhealthjournal.com/article/S1098-3015(11)03153-6/fulltext
Section Title :
Diabetes/Endocrine Disorders
Section Order :
1529
First Page :
A547
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)03153-6&doi=10.1016/j.jval.2011.08.1591